Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New formulation of Pfizer's Zeldox approved in Sweden; launch imminent

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Schering-Plough presents newly discovered selective M2 antagonists at ACS

Sep. 6, 2000

Prana to adapt Alzheimer's therapy for use in Creutzfeldt-Jakob disease

Sep. 6, 2000

Amides with cholinergic activity and their use disclosed by Fujisawa

Sep. 5, 2000

Noncompetitive dihydrophthalazine AMPA receptor antagonists synthesized at Annovis

Sep. 5, 2000

Sepracor completes large-scale U.S. efficacy study of (S)-zopiclone

Sep. 5, 2000

Preparation and use of novel nAChR ligands disclosed in recent patent

Sep. 4, 2000

Selective D3 receptor modulators and their use reported in BASF patent

Sep. 4, 2000

Micro Therapeutics to expand Onyx LES trial in brain aneurysm

Sep. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...